SCHEMBL22669139

SCHEMBL22669139

CC1(NC(=O)COc2ccc(Cl)c(Cl)c2)C=C(NC(=O)COCCc2ccc(F)cc2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ATF4 P18848 2/20 0.37
▸ GAA P10253 3/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ GRIN1 Q05586 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ADAMTS5 Q9UNA0 1/20 0.35
▸ SENP2 Q9HC62 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22669227 0.94 ATF4 (0.44) HPGDMEN1KMT2AATF4GAA
SCHEMBL22669514 0.93 ATF4 (0.41) MEN1KMT2AATF4GAANPC1
SCHEMBL22669522 0.92 MAPT (0.39) HPGDMEN1KMT2AGAANPC1
SCHEMBL22668967 0.91 HPGD (0.40) HPGDMEN1KMT2AATF4GAA
SCHEMBL22669335 0.91 MAOA (0.36) MEN1KMT2AATF4GAAGRIN1
SCHEMBL22669513 0.89 ATF4 (0.44) ATF4
SCHEMBL22669232 0.88 ATF4 (0.43) MEN1KMT2AATF4GAANPC1
SCHEMBL22669484 0.87 HTT (0.40) GAAGRIN1GRIN2BALDH1A1MAPT
SCHEMBL22669126 0.86 MAPK1 (0.39) MEN1KMT2AGAANPC1RAB9A
SCHEMBL20999049 0.84 ATF4 (0.51) ATF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2020-11-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 HPGD 849/4885MEN1 4714/4885KMT2A 4320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback